Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Steroids-Based Screening for Primary Aldosteronism

NCT06941116 is registered in ClinicalTrials.gov with Qifu Li as lead sponsor.

NCT NCT06941116
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06941116 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Steroids-Based Screening for Primary Aldosteronism
Lead sponsor
Qifu Li
Phase
Observational
Overall status
Recruiting
Start date
April 15, 2025
Completion date
December 30, 2026
Enrollment
406 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, primary aldosteronism